KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Current Assets (2016 - 2025)

Historic Current Assets for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to $18.0 billion.

  • Regeneron Pharmaceuticals' Current Assets fell 342.43% to $18.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.0 billion, marking a year-over-year decrease of 342.43%. This contributed to the annual value of $18.0 billion for FY2025, which is 342.43% down from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Current Assets stood at $18.0 billion, which was down 342.43% from $18.0 billion recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Current Assets registered a high of $19.5 billion during Q4 2023, and its lowest value of $10.1 billion during Q1 2021.
  • Its 5-year average for Current Assets is $16.5 billion, with a median of $16.9 billion in 2023.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Current Assets surged by 6968.52% in 2021, and later tumbled by 1164.52% in 2025.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Current Assets stood at $14.0 billion in 2021, then grew by 13.34% to $15.9 billion in 2022, then rose by 22.63% to $19.5 billion in 2023, then decreased by 4.2% to $18.7 billion in 2024, then dropped by 3.42% to $18.0 billion in 2025.
  • Its Current Assets stands at $18.0 billion for Q4 2025, versus $18.0 billion for Q3 2025 and $16.9 billion for Q2 2025.